Security key
H0036K147
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 34,683,534
- Share change
- +715,318
- Total reported value
- $155,728,721
- Put/Call ratio
- 36%
- Price per share
- $4.49
- Number of holders
- 36
- Value change
- +$7,168,355
- Number of buys
- 17
- Number of sells
- 21
Report period
Q1 2024
Institutions
36
Top holders
10
ADCT full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
ADC Therapeutics SA SEC filings
ADC Therapeutics SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP H0036K147
Recent filing periods:
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
12%
|
15,328,317
|
$25,445,006 | — | 31 Dec 2023 | |
| Prosight Management, LP |
13F
|
Company |
5%
|
6,471,800
|
$10,743,188 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
2,672,810
|
$4,436,865 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
1,853,412
|
$3,076,664 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
1,525,741
|
$2,532,730 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,459,514
|
$2,422,793 | — | 31 Dec 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.79%
|
1,013,540
|
$1,682,476 | — | 31 Dec 2023 | |
| Vantage Consulting Group Inc |
13F
|
Company |
0.66%
|
850,737
|
$1,412,224 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
781,937
|
$1,298,016 | — | 31 Dec 2023 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.57%
|
733,568
|
$1,217,723 | — | 31 Dec 2023 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.32%
|
410,888
|
$682,074 | — | 31 Dec 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.11%
|
144,858
|
$240,000 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
101,260
|
$168,092 | — | 31 Dec 2023 | |
| Indie Asset Partners, LLC |
13F
|
Company |
0.07%
|
92,700
|
$153,882 | — | 31 Dec 2023 | |
| Composition Wealth, LLC |
13F
|
Company |
0.07%
|
84,496
|
$140,263 | — | 31 Dec 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.06%
|
80,086
|
$132,000 | — | 31 Dec 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.05%
|
65,936
|
$109,454 | — | 31 Dec 2023 | |
| Magnetar Financial LLC |
13F
|
Company |
0.04%
|
55,762
|
$92,565 | — | 31 Dec 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
43,650
|
$72,459 | — | 31 Dec 2023 | |
| DLK Investment Management, LLC |
13F
|
Company |
0.03%
|
33,155
|
$55,037 | — | 31 Dec 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
21,848
|
$36,268 | — | 31 Dec 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
20,689
|
$34,344 | — | 31 Dec 2023 | |
| Saxony Capital Management, LLC |
13F
|
Company |
0.02%
|
20,623
|
$34,234 | — | 31 Dec 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
19,852
|
$33,000 | — | 31 Dec 2023 | |
| MONETA GROUP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.02%
|
19,496
|
$32,363 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
14,641
|
$24,304 | — | 31 Dec 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
14,000
|
$23,240 | — | 31 Dec 2023 | |
| EVERGREEN CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
11,000
|
$18,260 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
4,030
|
$7,000 | — | 31 Dec 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
2,232
|
$3,705 | — | 31 Dec 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,179
|
$1,000 | — | 31 Dec 2023 | |
| Focused Wealth Management, Inc |
13F
|
Company |
0%
|
300
|
$498 | — | 31 Dec 2023 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
250
|
$415 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
207
|
$344 | — | 31 Dec 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$166 | — | 31 Dec 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
20
|
$33 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
6
|
$10 | — | 31 Dec 2023 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
—
class O/S missing
|
1
|
$13 | — | 31 Dec 2023 |
Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q1 2024
As of 31 Mar 2024,
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,683,534 shares.
The largest 10 holders included
Redmile Group, LLC, Prosight Management, LP, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, Vantage Consulting Group Inc, and Blue Owl Capital Holdings LP.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
36
Q1 2024 holders
36
Holder diff
0
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.